Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2026-03-04 @ 11:48 AM
Study NCT ID:
NCT02903160
Status:
COMPLETED
Last Update Posted:
2024-02-07
First Post:
2016-09-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)
Sponsor:
Icahn School of Medicine at Mount Sinai
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Prostate Cancer | View |